OrbitonOpen research workspace →
Eli Lilly and Company logo

Eli Lilly and Company

NYSE:LLYLive AI agent

Investor relations information for Eli Lilly and Company (NYSE:LLY).

Investor website: https://lilly.com/

Verified company data

Shares outstanding
943,357,420
Projects
["not discovered"]
Leadership
Diogo Rau (Executive Vice President and Chief Information and Digital Officer, Leads Lilly’s information technology, cybersecurity, digital health, and advanced analytics and data science functions. Joined Lilly in May 2021 after a decade at Apple, where he developed technology for retail and online stores.), Tim Garnett, M.D. (Leader of the Development Center of Excellence, Responsible for medical, regulatory, global product safety, translational medicine and global health outcomes.), Tom Verhoeven, Ph.D. (Senior Vice President of Global Product Development, Oversees therapeutic area platform teams and global clinical operations.), John H. Johnson (Leader of the oncology business unit, Former CEO of ImClone Systems.), Enrique A. Conterno (President of Lilly USA, Joined Lilly as a sales representative in 1992 and has held various leadership roles.), Bryce D. Carmine (Executive Vice President, Global Marketing and Sales, Has held multiple leadership roles in marketing and management since joining Lilly in 1975.), Jacques Tapiero (President of the intercontinental region, Joined Lilly in 1983 and has held various sales and finance positions.), Jeff N. Simmons (President of Elanco, Joined Lilly in 1989 and has held numerous positions within Elanco.)

Verified data last updated:

Recent filings